Roche Will Co-Promote Fujisawa's Mycamine With Rociphen Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche's hospital sales force will "augment" Fujisawa's promotion of the antifungal. Roche will be compensated based on product sales. Mycamine will be available within the next month, Fujisawa says.
You may also be interested in...
Astellas Seeks Mycamine Candidemia Claim With sNDA
Antifungal facing additional competition this year following approval of Pfizer, Schering-Plough products.
Astellas Seeks Mycamine Candidemia Claim With sNDA
Antifungal facing additional competition this year following approval of Pfizer, Schering-Plough products.
Rocephin Generics Ship After Roche’s Ceftriaxone Patent Expires
Roche is forecasting a "classic erosion" of its injectable antibiotic Rocephin (ceftriaxone) after patent protection expired July 19